Microfluidic Targeted Microbubble Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing targeted microbubbles for ultrasound molecular imaging lack standardization and reproducibility, leading to variability in size distribution and acoustic response, which affects imaging sensitivity and clinical translation.
Innovation Solution
A method involving the use of microfluidic devices to produce phospholipid-ligand bioconjugates with site-specific conjugation of affibodies to phospholipid polymers, followed by incorporation into microbubbles using a microfluidic system, ensuring uniform size and enhanced binding affinity to specific biomarkers like B7-H3.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If mechanical agitation methods are used to produce microbubbles, then production efficiency is improved, but size distribution uniformity deteriorates
Solution Approach 1:
The patent replaces mechanical agitation methods with microfluidic-based processing methods. The microfluidic device uses precisely controlled flow of gas and liquid streams through specific channel geometry to produce microbubbles, eliminating the need for mechanical agitation while achieving better size uniformity and distribution control.
Solution Approach 2:
The patent employs microfluidic techniques that utilize precisely controlled flow of gas and liquid streams through microchannels. The flow-focusing microfluidic device uses hydraulic and pneumatic control to generate microbubbles with consistent size and distribution, replacing mechanical agitation with fluid dynamics-based control.
2Manufacturing precision
If standardized methodology is implemented for targeted microbubble production, then manufacturing precision is improved, but device complexity increases
Solution Approach 1:
The patent develops a universal microfluidic platform that can produce targeted microbubbles with standardized methodology. The microfluidic device integrates multiple functions including precise flow control, bubble generation, and ligand incorporation into a single system, enabling reproducible production without requiring complex separate processing steps.
Solution Approach 2:
The patent utilizes precisely controlled flow parameters and microchannel geometry to achieve standardized microbubble production. By optimizing and controlling flow rates, pressure, and channel dimensions, the system achieves reproducible size distribution and ligand labeling consistency without requiring overly complex procedural steps.
3Manufacturing precision
If microfluidic-based processing methods are used, then manufacturing precision is improved, but ease of manufacture deteriorates
Solution Approach 1:
The patent replaces complex mechanical agitation and sonication techniques with a microfluidic-based system that uses controlled fluid flow. This substitution simplifies the manufacturing process by eliminating the need for complex mechanical devices while maintaining precise control over microbubble size dispersity through microchannel geometry and flow parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in uniformly targeted microbubbles with improved ultrasound scattering properties and reproducible production, enhancing imaging sensitivity and clinical translatability by maintaining ligand functionality and stability.
Implementation Method 1
contacting a phospholipid polymer comprising a maleimide-containing functional group, with a ligand comprising a C terminal cysteine residue
Implementation Method 2
Microfluidic devices produce MBs by a variety of pinch-off mechanisms with precisely controlled flow of gas and liquid streams
Implementation Method 3
MBs have higher ultrasound scattering properties over a wide range of frequencies compared to those formed by mechanical agitation methods
Data Source
AI summary
Methods and compositions for the production of phospholipid-ligand bioconjugates and uniform targeted microbubbles are provided. These methods and compositions find use in ultrasound and molecular imaging applications related to cancer and other diseases. The methods of the present disclosure comprise contacting a phospholipid comprising a maleimide containing functional group with a ligand comprising a C terminal cysteine residue. The methods disclosed herein solves the problems in producing ready-to-use and clinically translatable ultrasound molecular imaging agents by incorporating small protein ligands engineered to bind against biomarkers representing pathological angiogenesis or abnormal cells. The methods also overcome the current limitations in producing uniformly targeted microbubbles in a scalable, economical and reproducible manner.